Human CXCL9 Protein (CXL-HM201) Summary
Product Description |
Recombinant Human CXCL9 Protein is expressed from HEK293 with hFc (IgG1) tag at the N-terminus.It contains Thr23-Thr125. |
Product Background |
Chemokine CXCL9 is a member of the CXC family and has an important role in the chemotaxis of immune cells. It is secreted by various cell types including immune cells (T lymphocytes, NK cells 3, dendritic cells 4, macrophages 5, eosinophils 6, etc.), and non-immune cells (hepatic stellate cells 7, preadipocytes, thyrocytes 8, endothelial cell, tumor cells, and fibroblasts 9, etc). CXCL9 has a versatile and controversial role in tumors, and accumulating evidence suggests that CXCL9 is closely associated with the prognosis of tumor patients. |
Product Category |
Recombinant Protein / Antibody discovery / Antibody discovery/Others |
Human CXCL9 Protein (CXL-HM201) Specifications/Details
Protein |
CXCL9 |
Synonyms |
C-X-C motif chemokine 9; MIG; CMK; SCYB9; Crg-10; Humig |
Accession |
|
Species |
Human |
Biotinylated |
no |
Amino Acid Range |
Thr23-Thr125 |
Molecular Weight |
The protein has a predicted MW of 37.67 kDa. Due to glycosylation, the protein migrates to 42-52 kDa based on Bis-Tris PAGE result. |
Product Tag |
N-hFc (IgG1) |
Fluorophore |
Unconjugated |
Expression System |
HEK293 |
Purity |
> 95% as determined by Bis-Tris PAGE;> 90% as determined by HPLC |
Endotoxin |
Less than 0.1 EU per ug by the LAL method. |
Shipping, Reconstitution, & Storage
Form |
Liquid |
Shipping |
Shipped with dry ice. |
Formulation |
Supplied as 0.22 um filtered solution in PBS (pH 7.4). |
Stability And Storage |
Valid for 12 months from date of receipt when stored at -80°C.; Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
Other Available Proteins:
Finding available proteins...
Related Products
Have more questions?
Check out our Frequently Asked Questions page for more details about product specifications, ordering, and shipments.
Contact Us
Recommended Products
Loading...
Recently viewed